BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30111376)

  • 21. Estimation of geometrically undistorted B(0) inhomogeneity maps.
    Matakos A; Balter J; Cao Y
    Phys Med Biol; 2014 Sep; 59(17):4945-59. PubMed ID: 25109506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study.
    Lütgendorf-Caucig C; Fotina I; Stock M; Pötter R; Goldner G; Georg D
    Radiother Oncol; 2011 Feb; 98(2):154-61. PubMed ID: 21176984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A; Töws N; Schmidberger H; Hess CF
    Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapy.
    Dowling JA; Lambert J; Parker J; Salvado O; Fripp J; Capp A; Wratten C; Denham JW; Greer PB
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e5-11. PubMed ID: 22330995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of volumes of prostate, rectum, and bladder on treatment planning CT on interfraction prostate shifts during ultrasound image-guided IMRT.
    Reddy NM; Nori D; Sartin W; Maiorano S; Modena J; Mazur A; Osian A; Sood B; Ravi A; Sampath S; Lange CS
    Med Phys; 2009 Dec; 36(12):5604-11. PubMed ID: 20095273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Image Distortions on a Plastic Interstitial Computed Tomography/Magnetic Resonance Brachytherapy Applicator at 3 Tesla Magnetic Resonance Imaging and Their Dosimetric Impact.
    van Heerden LE; van Kesteren Z; Gurney-Champion OJ; Houweling AC; Koedooder K; Rasch CRN; Pieters BR; Bel A
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):710-718. PubMed ID: 29280466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propagation of target and organ at risk contours in radiotherapy of prostate cancer using deformable image registration.
    Thörnqvist S; Petersen JB; Høyer M; Bentzen LN; Muren LP
    Acta Oncol; 2010 Oct; 49(7):1023-32. PubMed ID: 20831491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cone beam CT-Based Study for Clinical Target Definition Using Pelvic Anatomy During Postprostatectomy Radiotherapy.
    Showalter TN; Nawaz AO; Xiao Y; Galvin JM; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):431-6. PubMed ID: 17869021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer.
    Davidson MT; Blake SJ; Batchelar DL; Cheung P; Mah K
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1550-8. PubMed ID: 21543164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deformation of prostate and seminal vesicles relative to intraprostatic fiducial markers.
    van der Wielen GJ; Mutanga TF; Incrocci L; Kirkels WJ; Vasquez Osorio EM; Hoogeman MS; Heijmen BJ; de Boer HC
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1604-1611.e3. PubMed ID: 19028284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sectional anatomy of the pelvis in the male rat with ultrasound correlations.
    Suzuki T; Takezawa Y; Tamura Y; Mashimo T; Imai K; Yamanaka H; Suzuki K
    Anat Rec; 1991 Oct; 231(2):275-85. PubMed ID: 1746726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
    Thörnqvist S; Muren LP; Bentzen L; Hysing LB; Høyer M; Grau C; Petersen JB
    Acta Oncol; 2013 Apr; 52(3):521-7. PubMed ID: 23409771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient preparation and image quality in female pelvic MRI: recommendations revisited.
    Sheikh-Sarraf M; Nougaret S; Forstner R; Kubik-Huch RA
    Eur Radiol; 2020 Oct; 30(10):5374-5383. PubMed ID: 32356160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic half Fourier acquisition, single shot turbo spin-echo magnetic resonance imaging for evaluating the female pelvis.
    Gousse AE; Barbaric ZL; Safir MH; Madjar S; Marumoto AK; Raz S
    J Urol; 2000 Nov; 164(5):1606-13. PubMed ID: 11025716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetric effect of online image-guided anatomical interventions for postprostatectomy cancer patients.
    Diot Q; Olsen C; Kavanagh B; Raben D; Miften M
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):623-32. PubMed ID: 20643519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of prostate motion by removal of gas in rectum during radiotherapy.
    Ogino I; Uemura H; Inoue T; Kubota Y; Nomura K; Okamoto N
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):456-66. PubMed ID: 18374517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the impact of pelvic organ motion on dose delivered to target volumes during IMRT for cervical cancer.
    Eminowicz G; Rompokos V; Stacey C; Hall L; McCormack M
    Radiother Oncol; 2017 Jan; 122(1):116-121. PubMed ID: 27863962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy.
    Pasquier D; Cavillon F; Lacornerie T; Touzeau C; Tresch E; Lartigau E
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):549-54. PubMed ID: 22677369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer.
    Salembier C; Villeirs G; De Bari B; Hoskin P; Pieters BR; Van Vulpen M; Khoo V; Henry A; Bossi A; De Meerleer G; Fonteyne V
    Radiother Oncol; 2018 Apr; 127(1):49-61. PubMed ID: 29496279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.